PreeyaKshettryGuptaMD
Ophthalmology • Raleigh, NCAnterior Segment Related, Cataract Related, Cornea & External Disease, Refractive Surgery
Assistant Professor of Ophthalmology, Duke University School of Medicine
Dr. Gupta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9650 Brier Creek Pkwy
Ste 103
Raleigh, NC 27617Phone+1 919-391-7224Fax+1 919-660-5070
Education & Training
Duke University HospitalResidency, Ophthalmology, 2007 - 2010
Loyola Medicine MacNeal HospitalInternship, Transitional Year, 2006 - 2007
Northwestern University The Feinberg School of MedicineClass of 2006
Certifications & Licensure
NC State Medical License 2007 - 2025
SC State Medical License 2023 - 2025
MN State Medical License 2010 - 2012- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 3 citationsThe Effect of OTX-101 on Tear Production in Patients with Severe Tear-deficient Dry Eye Disease: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies.Melissa Toyos, Preeya K. Gupta, Brittany Mitchell, Paul M. Karpecki
Current Eye Research. 2021-08-29 - 1193 citationsTFOS DEWS II Diagnostic Methodology reportJames S. Wolffsohn, Reiko Arita, Robin L. Chalmers, Ali R. Djalilian, Murat Dogru
The Ocular Surface. 2017-07-01 - 15 citationsClinical Outcomes of Lifitegrast 5% Ophthalmic Solution in the Treatment of Dry Eye Disease.Amy Y. Tong, Samuel F Passi, Preeya K. Gupta
Eye & Contact Lens. 2020-01-01
Authored Content
- Meibomian Gland Atrophy in Children More Common Than Previously DescribedJune 2018
Press Mentions
CSF-1 Low-Dose Pilocarpine Improves Vision Outcomes in PresbyopiaNovember 12th, 2024- Bausch + Lomb and Novaliq Announce FDA Approval of MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) for the Treatment of the Signs and Symptoms of Dry Eye DiseaseMay 21st, 2023
- Sight Sciences’ Glaucoma and Dry Eye Technologies to Be Featured in Multiple Clinical Presentations at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual MeetingMay 1st, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
